SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001610618-19-000035
Filing Date
2019-05-09
Accepted
2019-05-09 16:16:01
Documents
54
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 CIDARA THERAPEUTICS, INC. FORM 10-Q cdtx10-q2019x03.htm 10-Q 945120
2 CERTIFICATION OF CEO PURSUANT TO SECURITIES EXCHANGE ACT OF 1934 exhibit311.htm EX-31.1 9944
3 CERTIFICATION OF CFO PURSUANT TO SECURITIES EXCHANGE ACT OF 1934 exhibit312.htm EX-31.2 9913
4 CERTIFICATION OF CEO PURSUANT TO SARBANES-OXLEY ACT OF 2002 exhibit321.htm EX-32.1 7280
5 CERTIFICATION OF CFO PUSRUANT TO SARBANES-OXLEY ACT OF 2002 exhibit322.htm EX-32.2 7402
  Complete submission text file 0001610618-19-000035.txt   4155910

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cdtx-20190331.xml EX-101.INS 614576
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cdtx-20190331.xsd EX-101.SCH 37055
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cdtx-20190331_cal.xml EX-101.CAL 53559
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cdtx-20190331_def.xml EX-101.DEF 174980
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cdtx-20190331_lab.xml EX-101.LAB 515842
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cdtx-20190331_pre.xml EX-101.PRE 292020
Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Filer) CIK: 0001610618 (see all company filings)

IRS No.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36912 | Film No.: 19810737
SIC: 2836 Biological Products, (No Diagnostic Substances)